Filing Details

Accession Number:
0001225208-16-034012
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-05-26 10:07:56
Reporting Period:
2016-05-24
Filing Date:
2016-05-26
Accepted Time:
2016-05-26 10:07:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
78003 Pfizer Inc PFE Pharmaceutical Preparations (2834) 135315170
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1174449 V Loretta Cangialosi Pfizer Inc.-Corp. Secretary
235 East 42Nd St.
New York NY 10017
Sr. Vice President, Controller No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-05-24 86,000 $25.87 271,663 No 4 M Direct
Common Stock Disposition 2016-05-24 500 $33.98 271,163 No 4 S Direct
Common Stock Disposition 2016-05-24 16,669 $33.95 254,494 No 4 S Direct
Common Stock Disposition 2016-05-24 18,231 $33.99 236,263 No 4 S Direct
Common Stock Disposition 2016-05-24 19,642 $33.97 216,621 No 4 S Direct
Common Stock Disposition 2016-05-24 30,958 $33.96 185,663 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2016-05-24 86,000 $0.00 86,000 $25.87
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2010-02-22 2017-02-21 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,067 Indirect By Rule 16b-3 Plan